From the perspective of reducing the survival rate of tumor cells under high temperatures and enhancing tumor immunotherapy, the synergistic treatment of YAP inhibitors and photothermal therapy undoubtedly has clinical potential. This evidence concerns the gene YAP1 and neoplasm.